This is a well-written study that presents a solid genetic screen to identify regulators of adipose morphology and remodeling in zebrafish. The authors generated a rigorous screening platform based on ...

The CTX310 results also raise excitement around CRISPR Therapeutics’ other in vivo candidate, CTX320, which is being developed in a phase I study for targeting lipoprotein (a), also associated ...

In vitro or ex vivo CRISPR-based screens also help researchers identify genes with therapeutic potential, such as viable targets for anticancer immunotherapy. CRISPR gene editing tools can also ...

Journal: Proceedings of the National Academy of Sciences of the United States of America Published: 2024-09-24 DOI: 10.1073/pnas.2406325121 Affiliations: 8 Authors: 22 ...

Intellia (NTLA) announces first-ever, promising clinical data on an in vivo CRISPR-based therapy. Stocks of CRSP, EDIT and BEAM rise on investor enthusiasm about their CRISPR-based candidates.

Shares of CRISPR Therapeutics CRSP have risen 14% over the past month, likely driven by encouraging results from the first candidates in its in vivo pipeline. CRSP’s Positive In Vivo Therapy ...

Shares of CRISPR Therapeutics CRSP have risen 14% over the past month, likely driven by encouraging results from the first candidates in its in vivo pipeline. CRSP’s Positive In Vivo Therapy ...